Your BOD and leadership can’t honestly think you have the chops to create value for shareholders by going it alone. Your US share will be eaten by generics and you’ll burn too much cash launching in EU yourselves.
My question is was there ever any real interest from big Pharma to buy this company?
Number 1 job is to drive shareholder value. Karim needs to take helm NOW and get to work!
My question is was there ever any real interest from big Pharma to buy this company?
Number 1 job is to drive shareholder value. Karim needs to take helm NOW and get to work!